AbC-19_rapid_antibody_test

AbC-19 rapid antibody test

AbC-19 rapid antibody test

Immunological test for COVID-19 exposure

The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1] This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1][2]

See also

References

  1. [1]
    "AbC-19 | COVID-19 Rapid Antibody Test and Certificate Solution | IgG". Abingdon Health plc. Retrieved 2 August 2021.
  2. [2]
    Mulchandani, R; Jones, HE; Taylor-Phillips, S; Shute, J; Perry, K; Jamarani, S; Brooks, T; Charlett, A; Hickman, M; Oliver, I; Kaptoge, S; Danesh, J; Di Angelantonio, E; Ades, AE; Wyllie, DH; EDSAB-HOME and COMPARE, Investigators. (11 November 2020). "Accuracy of UK Rapid Test Consortium (UK-RTC) "AbC-19 Rapid Test" for detection of previous SARS-CoV-2 infection in key workers: test accuracy study". BMJ (Clinical Research Ed.). 371: m4262. doi:10.1136/bmj.m4262. PMC 7656121. PMID 33177070.


Stub icon

This immunology article is a stub. You can help Wikipedia by expanding it.

Stub icon

This United Kingdom-related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article AbC-19_rapid_antibody_test, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.